NPDC-1 inhibitors are a class of chemical compounds that target the neural proliferation, differentiation, and control protein-1 (NPDC-1), a protein primarily involved in regulating neural development and cell cycle processes in the nervous system. NPDC-1 is known to modulate the activity of various transcription factors and signaling pathways that influence neural cell differentiation, proliferation, and apoptosis. The protein is particularly important in the maturation and development of neurons, as it interacts with key molecules that control the transition from proliferation to differentiation in neural progenitor cells. NPDC-1 inhibitors work by interfering with the function of this protein, potentially altering neural development and cellular processes governed by NPDC-1.
The mechanism of NPDC-1 inhibitors can involve direct binding to NPDC-1, disrupting its interactions with transcription factors and other regulatory proteins. By doing so, these inhibitors may prevent NPDC-1 from exerting its control over cell cycle progression, particularly in neural cells, leading to alterations in the balance between cell proliferation and differentiation. Additionally, some NPDC-1 inhibitors may affect the protein's role in modulating signaling pathways involved in neurogenesis, thus providing insight into how NPDC-1 contributes to neural development and the maintenance of the nervous system. These inhibitors are important tools for understanding the specific molecular mechanisms that regulate neural cell behavior, offering insights into the role of NPDC-1 in controlling the dynamics of neurodevelopmental processes and how disruptions in NPDC-1 function can impact the nervous system.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May downregulate NPDC-1 by promoting the demethylation of CpG islands within the gene promoter, thereby silencing gene transcription through epigenetic remodeling. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Could decrease NPDC-1 expression by hindering histone deacetylase activity, leading to an accumulation of acetylated histones and a reduction in transcriptional initiation at the gene locus. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
May reduce NPDC-1 expression by inhibiting histone deacetylase, which can cause the accumulation of acetylated histones and subsequent transcriptional repression of the gene. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Could downregulate NPDC-1 by inhibiting histone deacetylase, leading to enhanced acetylation of histones near the NPDC-1 promoter and transcriptional repression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
May reduce NPDC-1 expression by binding to retinoic acid receptors, which may alter gene expression patterns including the suppression of NPDC-1 during differentiation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Might inhibit NPDC-1 expression by specifically downregulating the mTOR pathway, which is known to control global protein synthesis, including that of NPDC-1. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Could decrease NPDC-1 transcription by binding tightly to DNA, thus obstructing RNA polymerase movement and transcriptional progression across the NPDC-1 gene. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
May reduce NPDC-1 protein levels by blocking the translocation step in protein synthesis, leading to a decrease in the production of the NPDC-1 protein and potentially its mRNA stability. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Potentially could decrease NPDC-1 expression by introducing DNA crosslinks at the gene locus, thereby hindering the transcriptional machinery from accessing the gene. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Could inhibit NPDC-1 transcription by selectively binding to guanine-cytosine-rich DNA sequences in the promoter region, blocking transcription factor access and gene transcription. | ||||||